StonvexLoading…
StonvexStonvexStonvexCore line items from CRL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.02B | $4.05B | $4.13B | $3.98B |
Operating Income | $25.16M | $227.35M | $617.26M | $650.98M |
Net Income | $-144.34M | $22.20M | $474.62M | $486.23M |
EPS (Diluted) | $-2.91 | $0.20 | $9.22 | $9.48 |
Total Assets | $7.14B | $7.53B | $8.20B | $7.60B |
Total Liabilities | $3.92B | $4.02B | $4.54B | $4.58B |
Cash & Equivalents | $213.77M | $194.61M | $276.77M | $233.91M |
Free Cash Flow OCF − CapEx | $518.49M | $501.61M | $365.37M | $294.91M |
Shares Outstanding | 49.22M | 51.14M | 51.34M | 50.94M |